Graham Packham
Graham Packham
Email verificata su
Citata da
Citata da
The ornithine decarboxylase gene is a transcriptional target of c-Myc
C Bello-Fernandez, G Packham, JL Cleveland
Proceedings of the National Academy of Sciences 90 (16), 7804-7808, 1993
High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27kip1 and degree of malignancy in human breast …
S Fredersdorf, J Burns, AM Milne, G Packham, L Fallis, CE Gillett, ...
Proceedings of the National Academy of Sciences 94 (12), 6380-6385, 1997
B-cell receptor signaling in chronic lymphocytic leukemia
FK Stevenson, S Krysov, AJ Davies, AJ Steele, G Packham
Blood, The Journal of the American Society of Hematology 118 (16), 4313-4320, 2011
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia
S Lanham, T Hamblin, D Oscier, R Ibbotson, F Stevenson, G Packham
Blood, The Journal of the American Society of Hematology 101 (3), 1087-1093, 2003
Chronic lymphocytic leukaemia
TJ Kipps, FK Stevenson, CJ Wu, CM Croce, G Packham, WG Wierda, ...
Nature reviews Disease primers 3 (1), 1-22, 2017
c-Myc and apoptosis
G Packham, JL Cleveland
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1242 (1), 11-28, 1995
Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis.
G Packham, JL Cleveland
Molecular and Cellular Biology 14 (9), 5741-5747, 1994
J Michels, PWM Johnson, G Packham
The international journal of biochemistry & cell biology 37 (2), 267-271, 2005
Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia.
LS Young, R Lau, M Rowe, G Niedobitek, G Packham, F Shanahan, ...
Journal of Virology 65 (6), 2868-2874, 1991
Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma
T Armstrong, G Packham, LB Murphy, AC Bateman, JA Conti, DR Fine, ...
Clinical Cancer Research 10 (21), 7427-7437, 2004
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status
C Ian Mockridge, KN Potter, I Wheatley, LA Neville, G Packham, ...
Blood 109 (10), 4424-4431, 2007
Bodyguards and assassins: Bcl‐2 family proteins and apoptosis control in chronic lymphocytic leukaemia
G Packham, FK Stevenson
Immunology 114 (4), 441-449, 2005
Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation
Biochemical Journal 328 (3), 807-813, 1997
E2F-1: DP-1 induces p53 and overrides survival factors to trigger apoptosis.
SW Hiebert, G Packham, DK Strom, R Haffner, M Oren, G Zambetti, ...
Molecular and Cellular Biology 15 (12), 6864-6874, 1995
BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability
M Brimmell, R Mendiola, J Mangion, G Packham
Oncogene 16 (14), 1803-1812, 1998
BAG-1: a multifunctional regulator of cell growth and survival
PA Townsend, RI Cutress, A Sharp, M Brimmell, G Packham
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1603 (2), 83-98, 2003
Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1
CM Eischen, G Packham, J Nip, BE Fee, SW Hiebert, GP Zambetti, ...
Oncogene 20 (48), 6983-6993, 2001
Induction of cytosolic calcium flux by CD20 is dependent upon B Cell antigen receptor signaling
CA Walshe, SA Beers, RR French, CHT Chan, PW Johnson, GK Packham, ...
Journal of Biological Chemistry 283 (25), 16971-16984, 2008
Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage
J Michels, JW O'Neill, CL Dallman, A Mouzakiti, F Habens, M Brimmell, ...
Oncogene 23 (28), 4818-4827, 2004
MicroRNAs: key players in carcinogenesis and novel therapeutic targets
AHF Mirnezami, K Pickard, L Zhang, JN Primrose, G Packham
European Journal of Surgical Oncology (EJSO) 35 (4), 339-347, 2009
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20